Adlai Nortye Ltd. – Filings and Transcripts

NASDAQ: ANL
Share price (4/2/26): $8.18
Market cap (4/2/26): $450 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024 – amended

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement with pricing info

Initial registration of new securities for foreign issuers – amended

Ownership Filter

Venrock Healthcare Capital Partners III, L.P.

Unique Mark Ventures Ltd

Unique Mark Ventures Ltd

Boary Investment Co. Ltd.

News Filter

Management Change of the Company

Announces First Patient Enrolled in Global Phase 1 Trial of Pan-Ras (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations

Announces $140.0 Million Private Placement Equity Financing

Enters Exclusive License Agreement With ASK Pharm for Pan-Ras (ON) Inhibitor AN9025 in Greater China

Material disclosure

Proxies

No filings in this category.

Other Filter

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness